References
- Ellis ER, Josephson ME. Heart failure and tachycardia-induced
cardiomyopathy, Curr Heart Fail Rep. 2013;10(4):296-306.
- Gossage AM, Braxton Hicks JA. On auricular fibrillation. QJ Med 1913;
6(4): 435–440
- Neumann T, Ravens U, Heusch G. Characterization of
excitation-contraction coupling in conscious dogs with pacing-induced
heart failure. Cardiovasc Res 1998;37:456–66.
- Ravens U, Davia K, Davies CH, O’Gara P, Drake-Holland AJ, Hynd JW,
Noble MI, Harding SE. Tachycardia-induced failure alters contractile
properties of canine ventricular myocytes. Cardiovasc Res
1996;32:613–21.
- Shinbane JS, Wood MA, Jensen DN, Ellenbogen KA, Fitzpatrick AP,
Scheinman MM. Tachycardia-induced cardiomyopathy: a review of animal
models and clinical studies. J Am Coll Cardiol 1997;29:709–15.
- Zellner JL, Spinale FG, Eble DM, Hewett KW, Crawford FA Jr.
Alterations in myocyte shape and basement membrane attachment with
tachycardia-induced heart failure. Circ Res 1991; 69:590–600.
- Kajstura J, Zhang X, Liu Y, Szoke E, Cheng W, Olivetti G, Hintze H,
Anversa P. The cellular basis of pacing-induced dilated
cardiomyopathy: myocyte cell loss and myocyte cellular reactive
hypertrophy. Circulation 1995;92:2306–17.
- Mueller KAL, Heinzmann D, Klingel K, Fallier-Becker P, Kandolf R,
Kilias A, Walker-Allgaier B, Borst O, Kumbrink J, Kirchner T, Langer
H, Geisler T, Schreieck J, Gramlich M, Gawaz M, Seizer P.
Histopathological and Immunological Characteristics of
Tachycardia-Induced Cardiomyopathy. J Am Coll Cardiol.
2017;69(17):2160–72.
- Zhang Y, Guallar E, Blasco-Colmenares E, Butcher B, Norgard S, Nauffal
V, Marine JE, Eldadah Z, Dickfeld T, Ellenbogen KA, Tomaselli GF,
Cheng A. Changes in follow-up left ventricular ejection fraction
associated with outcomes in primary prevention implantable
cardioverter-defibrillator and cardiac resynchronization therapy
device recipients. J Am Coll Cardiol. 2015;66(5):524-31.
- Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P,
Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW,
Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K; ESC Committee
for Practice Guidelines (CPG). ESC Guidelines for the diagnosis and
treatment of acute and chronic heart failure 2008: the Task Force for
the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of
the European Society of Cardiology. Developed in collaboration with
the Heart Failure Association of the ESC (HFA) and endorsed by the
European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail
2008;29:2388–442.
- Leone O, Veinot JP, Angelini A, Baandrup UT, Basso C, Berry G,
Bruneval P, Burke M, Butany J, Calabrese F, d’Amati G, Edwards WD,
Fallon JT, Fishbein MC, Gallagher PJ, Halushka MK, McManus B, Pucci A,
Rodriguez ER, Saffitz JE, Sheppard MN, Steenbergen C, Stone JR, Tan C,
Thiene G, van der Wal AC, Winters GL. 2011 consensus statement on
endomyocardial biopsy from the Association for European Cardiovascular
Pathology and the Society for Cardiovascular Pathology. Cardiovasc
Pathol 2012;21:245–74
- Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix
SB, Fu M, Heliö T, Heymans S, Jahns R, Klingel K, Linhart A, Maisch B,
McKenna W, Mogensen J, Pinto YM, Ristic A, Schultheiss HP, Seggewiss
H, Tavazzi L, Thiene G, Yilmaz A, Charron P, Elliott PM.; European
Society of Cardiology Working Group on Myocardial and Pericardial
Diseases. Current state of knowledge on etiology, diagnosis,
management, and therapy of myocarditis: a position statement of the
European Society of Cardiology Working Group on Myocardial and
Pericardial Diseases. Eur Heart J 2013;34:2636–48.
- Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U,
Levine GN, Narula J, Starling RC, Towbin J, Virmani R. The role of
endomyocardial biopsy in the management of cardiovascular disease: a
scientific statement from the American Heart Association, the American
College of Cardiology, and the European Society of Cardiology. Eur
Heart J 2007;28:3076-93.
- Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D,
Moss AJ, Seidman CE, Young JB; American Heart Association; Council on
Clinical Cardiology, Heart Failure and Transplantation Committee;
Quality of Care and Outcomes Research and Functional Genomics and
Translational Biology Interdisciplinary Working Groups; Council on
Epidemiology and Prevention Contemporary definitions and
classification of the cardiomyopathies: an American Heart Association
Scientific Statement from the Council on Clinical Cardiology, Heart
Failure and Transplantation Committee; Quality of Care and Outcomes
Research and Functional Genomics and Translational Biology
Interdisciplinary Working Groups; and Council on Epidemiology and
Prevention. Circulation 2006;113:1807–16.
- Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS,
Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M,
Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano
GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P 2016 ESC
Guidelines for the diagnosis and treatment of acute and chronic heart
failure: The Task Force for the diagnosis and treatment of acute and
chronic heart failure of the European Society of Cardiology (ESC); Eur
Heart J 2016;37(27):2129–2200.
- Ohlow MA, Michel C, Chen TH, Schmidt A, Sänger J, Lauer B, Brunelli M.
Predictors of long-term outcome in patients with biopsy-proven
inflammatory cardiomyopathy. J Geriatr Cardiol 2018;15:363-371
- Ohlow MA, Chen TH, Schmidt A, Sänger J, Lauer B. Clinical profile of
patients with advanced age and inflammatory dilated cardiomyopathy on
endomyocardial biopsy. J Geriat Cardiol 2015;12:60-612
-